US Defibrillator Market (2025-2030)
The US Defibrillator Market was valued at $3285.8 Million in 2025 and projected to reach to $4376.38 Million by 2030, representing a compound annual growth rate of 5.9%. The US defibrillator market is poised for sustained growth through 2030, driven by increasing prevalence of sudden cardiac arrest, aging population demographics, and expanding AED placement initiatives in public and private sectors.
US Defibrillator Market Trends and Insights
- The US market benefits from advanced healthcare infrastructure, high adoption of automated external defibrillators (AEDs) in public spaces, and strong reimbursement policies that support device deployment across hospitals, clinics, and community settings.
- Increasing prevalence of cardiovascular diseases and sudden cardiac arrest incidents in the US continues to drive demand for both implantable and external defibrillation devices. Growth in the US defibrillator market is fueled by technological innovations, including wearable defibrillators and remote monitoring capabilities that enhance patient outcomes.
- The US regulatory environment, governed by the FDA, ensures rigorous safety and efficacy standards, which builds consumer confidence and supports market expansion.
- Strategic partnerships between device manufacturers and healthcare providers in the US are accelerating market penetration, particularly in underserved regions where AED accessibility remains a priority..
Key Market Statistics
- CAGR (2025-2030) 5.9% CAGR
- Market Size, 2025 ~USD 3285.8 Million
- Forecast, 2030 ~USD 4376.38 Million
- Country US
US Defibrillator Market Overview
Market Size & Growth :
The US defibrillator market is valued at $3,285.8 million in 2025 and is projected to reach $4,376.38 million by 2030, representing a steady CAGR of 5.9% over the forecast period.
AED Adoption in Public Spaces :
The US has witnessed significant expansion of automated external defibrillators (AEDs) in public locations including airports, schools, shopping centers, and corporate offices, driven by regulatory mandates and awareness campaigns.
Reimbursement Support :
Strong reimbursement policies from Medicare, Medicaid, and private insurers in the US facilitate widespread device deployment across hospitals, clinics, and emergency care facilities, supporting market growth.
Advanced Healthcare Infrastructure :
The US benefits from a mature healthcare system with high technology adoption rates, enabling rapid integration of next-generation defibrillator technologies and remote monitoring capabilities.
US Defibrillator Market Dynamics
- Healthcare providers are increasingly investing in advanced defibrillator technologies, including wearable devices and integrated monitoring systems, to improve patient outcomes and reduce mortality rates. Regulatory support and favorable reimbursement landscapes continue to accelerate market penetration across diverse healthcare settings.
- The growing emphasis on cardiac emergency preparedness in schools, workplaces, and community centers further strengthens demand.
- Additionally, technological innovations in device connectivity and data analytics are expected to create new revenue streams and enhance clinical decision-making capabilities throughout the forecast period..
Related Ecosystem
Cardiovascular Devices
- External Defibrillators
- Implantable Cardioverter Defibrillators
- Pulse Oximeters
- Robotic Systems
- 3-Lead ECG Leadwires
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Terumo Corporation
- KONINKLIJKE PHILIPS N.V.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- The US defibrillator market is valued at $3,285.8 million in 2025 and will reach $4,376.38 million by 2030, growing at 5.9% CAGR.
- Advanced healthcare infrastructure and strong FDA regulations position the US as a mature, high-confidence market for defibrillator adoption.
- Technological innovations such as wearable defibrillators and remote monitoring are key growth drivers in the US market.
- Strategic partnerships and AED deployment initiatives in public spaces are expanding market accessibility across the US.
Defibrillator Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | EXTERNAL DEFIBRILLATORS (Product) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.5% from 2025 to 2030 |
| Largest Segment | IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (Product) |
| Market Size Base Year (Billions) | ~USD 12 (2025) |
| Revenue Forecast (Billions) | ~USD 16.44 (2030) |
| Segments Covered | Product, Type, Patient Type, End User |
US Defibrillator Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- External Defibrillators
- Implantable Cardioverter Defibrillator
- Implantable Cardioverter Defibrillators
By Type
- Automated External Defibrillators
- Biventricular Icds/Cardiac Resynchronization Therapy Defibrillators
- Dual-Chamber Icds
- Fully Automated Defibrillators
- Fully Automated External Defibrillators
- Manual External Defibrillators
- Semi- Automated Defibrillators
- Semi-Automated External Defibrillators
- Single-Chamber Icds
- Subcutaneous Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
- Wearable Cardioverter Defibrillators
By Patient Type
- Adult Patients
- Pediatric Patients
By End User
- Cardiac Centers
- Home Care Settings
- Hospitals & Clinics
- Other End Users
- Prehospital Settings
- Public-Access Market
- Public-Access Markets
Target Audience
- Medical Device Manufacturers : Defibrillator manufacturers need US market intelligence to benchmark competitive positioning, identify market gaps, optimize product portfolios, and develop targeted go-to-market strategies for the American healthcare sector.
- Healthcare Providers & Hospital Systems : Hospital administrators and procurement teams require market data to make informed capital equipment decisions, evaluate vendor options, understand reimbursement implications, and plan cardiac care infrastructure investments.
- Investment & Private Equity Firms : Investors evaluating opportunities in the US medical device sector need comprehensive market sizing, growth trajectory analysis, and competitive dynamics to assess investment returns and portfolio company valuations.
- Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors require detailed US market data to support client strategy development, market entry planning, and competitive positioning recommendations in the defibrillator space.
- Regulatory & Policy Organizations : Government agencies, health policy organizations, and regulatory bodies use market research to inform public health initiatives, AED placement policies, reimbursement decisions, and cardiac emergency preparedness programs.
Key Companies in the US Defibrillator Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-related utilization,Oral drug regimen management,Topical and transdermal administration, |
| SORIN GROUP | Italy | Private Company | Cardiac surgery capital equipment (heart-lung machines, autotransfusion systems),Cardiac surgery disposables (oxygenators, circuits, autotransfusion sets),Heart valves and repair devices (mechanical, tissue, structureless, annuloplasty rings), |
| AT&S | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Lifecycle and post-automation services,Software and digital solutions, |
| CONMED CORPORATION | United States | Public Company | Orthopedic sports medicine & Hall power tools,General surgery: AirSeal, Buffalo Filter, endomechanical,Endoscopic technologies (GI) and therapeutic devices, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio (incl. patient monitoring & diabetes),Neuroscience Portfolio, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiac Rhythm Management and Electrophysiology,Structural Heart and LAAC (WATCHMAN FLX and related),Interventional Cardiology and Peripheral Vascular, |
| ABBOTT | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, molecular, point-of-care, rapid tests),Nutritional Products (pediatric, adult, infant formula), |
| ASAHI KASEI CORPORATION | Japan | Public Company | Semiconductor and electronics materials (Pimel, Sunfort, Novacure, glass fabric, sensors),Battery separators and energy-related membranes (Hipore, Celgard, Aqualyzer, Aciplex, Microza),Healthcare products and pharma (prescription drugs, virus filters, wearable defibrillators, ICU systems), |
| STRYKER | United States | Public Company | Orthopaedics (joints, trauma, extremities, Mako-linked implants),MedSurg equipment and patient handling/safety,Neurotechnology and stroke/venous therapies, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MRI, CT, Ultrasound, X-ray),Image Guided Therapy (systems and devices),Connected Care (Monitoring & Enterprise Informatics), |
| MICROPORT SCIENTIFIC CORPORATION | China | Public Company | Cardiovascular Devices (coronary stents, balloons, accessories),Orthopedics Devices (reconstructive joints, spine, trauma),Cardiac Rhythm Management (defibrillators, CRT, pacemakers), |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitoring & clinical information systems,Physiological measuring & neurodiagnostics (EEG/EMG/EP/ECG),Therapeutic devices (defibrillators, AEDs, ventilators, anesthesia, pacemakers, chest compression), |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | China | Public Company | Patient Monitoring, Anesthesia, Ventilation, and Defibrillation (incl. M-connect solutions),Ultrasound and Radiology / Medical Imaging,In-vitro Diagnostics (CLIA, Chemistry, Hematology), |
| CU MEDICAL SYSTEMS CO., LTD. | South Korea | Public Company | Automatic External Defibrillators (AEDs),Automated CPR Devices,Heart Rate Monitors and Functional Electrical Stimulation, |
| MEDIANA CO, LTD. | South Korea | Public Company | Patient monitors & vital signs monitors,AEDs & monitor/defibrillators,Fetal products & physio modules, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a private healthcare company founded in 1985 in the United States with 64,200 employees. The company operates as a major healthcare services provider in the U.S. market.
SORIN GROUP
Sorin Group is an Italian private company founded in 2004 with 3,940 employees. The company operates in the healthcare sector in Italy.
AT&S
AT&S is a Canadian public company founded in 1978 with 7,000 employees. The company operates in Canada's business sector.
CONMED CORPORATION
CONMED Corporation is a U.S. public company founded in 1970 with 3,900 employees. The company operates in the medical device and healthcare equipment industry.
MEDTRONIC
Medtronic is a public company founded in 1949 in Ireland with 95,000 employees. The company is a major global medical technology and healthcare solutions provider.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a U.S. public company founded in 1979 with 59,000 employees. The company is a leading developer and manufacturer of medical devices and healthcare solutions.
ABBOTT
Abbott is a U.S. public company founded in 1888 with 115,000 employees. The company is a diversified healthcare and pharmaceutical company with a global presence.
ASAHI KASEI CORPORATION
Asahi Kasei Corporation is a Japanese public company founded in 1922 with 47,895 employees. The company operates across multiple sectors including healthcare and materials.
STRYKER
Stryker is a U.S. public company founded in 1941 with 56,000 employees. The company is a leading medical technology company specializing in orthopedic and surgical products.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees. The company is a global diversified technology company with significant healthcare and lighting divisions.
MICROPORT SCIENTIFIC CORPORATION
MicroPort Scientific Corporation is a Chinese public company founded in 1998 with 6,547 employees. The company operates in the medical device and healthcare sector.
NIHON KOHDEN CORPORATION
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees. The company manufactures medical equipment and healthcare devices.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company is a leading manufacturer of medical devices and healthcare equipment.
CU MEDICAL SYSTEMS CO., LTD.
CU Medical Systems Co., Ltd. is a South Korean public company founded in 2001 with 118 employees. The company operates in the medical device sector.
MEDIANA CO, LTD.
Mediana Co, Ltd. is a South Korean public company founded in 1993 with 160 employees. The company operates in the healthcare and medical device industry.
Reasons to Buy this Report
- Market Size & Revenue Projections : Access precise valuation data for the US defibrillator market ($3,285.8M in 2025) with detailed forecasts through 2030, enabling accurate financial planning and investment decisions for market participants.
- Competitive Landscape Analysis : Understand the competitive positioning of major defibrillator manufacturers in the US market, including market share distribution, product portfolios, and strategic initiatives specific to the American healthcare ecosystem.
- Regulatory & Reimbursement Insights : Gain comprehensive understanding of US-specific regulatory requirements, FDA approval pathways, Medicare/Medicaid reimbursement policies, and insurance coverage criteria that directly impact market dynamics and profitability.
- Segment & Application Breakdown : Detailed segmentation by device type (ICDs, external defibrillators, wearables), end-user (hospitals, clinics, public spaces), and clinical applications enables targeted market entry and product development strategies.
- Growth Drivers & Market Opportunities : Identify key growth catalysts specific to the US market including aging demographics, AED placement mandates, technological innovations, and emerging opportunities in remote monitoring and connected health solutions.
Frequently asked questions
What is the current size of the US defibrillator market in 2025?
The US defibrillator market is valued at $3,285.8 million in 2025.
What is the projected size of the US defibrillator market by 2030?
The US defibrillator market is projected to reach $4,376.38 million by 2030.
What is the growth rate of the US defibrillator market?
The US defibrillator market is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2030.
What factors are driving growth in the US defibrillator market?
Key drivers include increasing cardiovascular disease prevalence, technological innovations like wearable defibrillators, strong FDA regulations, and expanded AED deployment in public spaces across the US.
Which segments dominate the US defibrillator market?
The US market includes implantable cardioverter-defibrillators (ICDs), automated external defibrillators (AEDs), and wearable defibrillators, with adoption driven by hospital, clinic, and community settings.
RESEARCH METHODOLOGY
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US Census Bureau, ), World Health Organization (WHO), World Bank, Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Health Canada, European Medicines Agency (EMA), Medicines and Healthcare Products Regulatory Agency (MHRA, UK), American College of Cardiology (ACC), American Heart Association, Centers for Medicare & Medicaid Services (CMS) were referred to identify and collect information for the global defibrillator market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pulse oximeters market. The primary sources from the demand side include key executives from hospitals, physicians, clinicians, and research institutes.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
All major product manufacturers offering various defibrillators were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value defibrillator market was also split into various segments and subsegments at the region and country level based on:
- Product mapping of various manufacturers for each type of defibrillator market at the regional and country level
- Relative adoption pattern of each defibrillator market among key end-user segments at the regional and/or country level
- Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
- Detailed secondary research to gauge the prevailing market trends at the regional and/or country level
Global Defibrillator Market: Top-Down & Bottom Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the defibrillator industry.
Market Definition
A defibrillator is a device that monitors the heart rhythm and delivers electric shocks upon detecting an abnormal heart rhythm to restore the normal heart rhythm. The device plays an important role in the management and treatment of sudden cardiac arrest.
Stakeholders
- Manufacturers of Defibrillators
- Distributors of Defibrillators
- Hospitals, Clinics, Cardiac Centers
- Non-government Organizations
- Government Regulatory Authorities
- Contract Manufacturers and Third-party Suppliers
- Research Laboratories and Academic Institutes
- Clinical Research Organizations (CROs)
- Government and Non-governmental Regulatory Authorities
Report Objectives
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To define, describe, segment, and forecast the defibrillator market by product, patient type, end user, and region
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall defibrillator market
- To forecast the size of the defibrillator market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players in the defibrillator market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments, such as acquisitions, product launches, expansions, collaborations, agreements, & partnerships, and R&D activities of the leading players in the defibrillator market
- To benchmark players within the defibrillator market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Get the Full Defibrillator Market Report
Full forecast, segment splits, and company analysis for all Defibrillator Market.
- Canada Defibrillator Market
- Germany Defibrillator Market
- UK Defibrillator Market
- France Defibrillator Market
- Italy Defibrillator Market
- Spain Defibrillator Market
- Japan Defibrillator Market
- China Defibrillator Market
- India Defibrillator Market
- Australia Defibrillator Market
- South Korea Defibrillator Market
- Brazil Defibrillator Market
- Mexico Defibrillator Market
- UAE Defibrillator Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report